Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Change in Receivables of -$302000.0 in Q1 2026, down 104.67% quarter-over-quarter from $6.5 million in Q4 2025, and up 61.03% on a YoY basis from -$187540.1 in Q1 2025.
Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Change in Receivables history runs 10 years deep, the most recent figure standing at -$302000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 61.03% year-over-year to -$302000.0; the TTM figure through Mar 2026 stood at $11.9 million (down 42.85% YoY), while the FY2025 annual figure was $11.5 million, down 56.36% from the prior year.
- Change in Receivables was -$302000.0 for Q1 2026 at Establishment Labs Holdings, down from $6.5 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.6 million in Q2 2023 to a low of -$8.1 million in Q4 2023.
- Historically, Change in Receivables has averaged $3.6 million across 5 years, with a median of $4.6 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables soared 2550.0% in 2022, then slumped 429.67% in 2023.
- A 5-year view of Change in Receivables shows it stood at $2.4 million in 2022, then plunged by 429.67% to -$8.1 million in 2023, then soared by 163.71% to $5.1 million in 2024, then rose by 25.79% to $6.5 million in 2025, then tumbled by 104.67% to -$302000.0 in 2026.
- The last three Change in Receivables figures came in at -$302000.0 (Q1 2026), $6.5 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -302,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | 6.47 Mn |
| Dec 31, 2025 | 6.47 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | -775,000.00 |
| Mar 31, 2025 | -775,000.00 |
| Dec 31, 2024 | 5.15 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | -8.08 Mn |
| Dec 31, 2023 | -8.08 Mn |